Literature DB >> 24370939

The metabolism of trifluoperazine (TFP) exhibits atypical kinetic behavior in both human liver microsomes (HLMs) and monkey liver microsomes (MyLM).

Jin-Fang Xiao1, Xiao-Jun Liu, Gao-Wang Liu, Xue-Ying Yang, Pan Xiao, Xiao-Min Hou, Hai-Tang Wang, Jian-Jun Tang, Ya-Ting Zhang, Chen Zhen, Hai-Hong Fang.   

Abstract

Glucuronidation reaction of trifluoperazine (TFP) is a typical probe reaction to phenotype the activity of UDP-glucuronosyltransferase 1A4. The present study aims to compare the metabolic behavior of TFP in the liver microsomes from human and cynomolgus monkey, including the kinetic type and parameters. In vitro human liver microsome incubation system was used. The Eadie-Hofstee plot was used to determine the kinetic type. The results showed that the data for human liver microsomes (HLMs) and monkey liver microsomes (MyLMs)-catalyzed glucuronidation were best fit to the substrate inhibition model. For the metabolism of TFP in HLMs, the kinetic parameters were calculated to be 40 ± 5 and 140 ± 20 μM for K m and K si values, respectively. For the MyLM-mediated metabolism of TFP, the K m and K si values were calculated to be 108 ± 10 and 250 ± 30 μM, respectively. The same metabolic kinetic type and different kinetic parameters were demonstrated for the metabolism of TFP between HLMs and MyLMs. All these data were helpful for understanding the metabolism difference of TFP between human and monkey.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24370939     DOI: 10.1007/s13318-013-0163-8

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  14 in total

1.  Simultaneous evaluation of six human glucuronidation activities in liver microsomes using liquid chromatography-tandem mass spectrometry.

Authors:  Anne-Laure Gagez; Koukeb Rouguieg-Malki; François-Ludovic Sauvage; Pierre Marquet; Nicolas Picard
Journal:  Anal Biochem       Date:  2012-05-10       Impact factor: 3.365

2.  The effects of N-glycosylation on the glucuronidation of zidovudine and morphine by UGT2B7 expressed in HEK293 cells.

Authors:  Kenjiro Nagaoka; Nobumitsu Hanioka; Shinichi Ikushiro; Shigeru Yamano; Shizuo Narimatsu
Journal:  Drug Metab Pharmacokinet       Date:  2012-01-13       Impact factor: 3.614

3.  UGT1A4*3 encodes significantly increased glucuronidation of olanzapine in patients on maintenance treatment and in recombinant systems.

Authors:  T Haslemo; I Loryan; N Ueda; B Mannheimer; L Bertilsson; M Ingelman-Sundberg; E Molden; E Eliasson
Journal:  Clin Pharmacol Ther       Date:  2012-06-20       Impact factor: 6.875

4.  Species differences in intestinal metabolic activities of cytochrome P450 isoforms between cynomolgus monkeys and humans.

Authors:  Haruka Nishimuta; Kimihiko Sato; Yasuyuki Mizuki; Masashi Yabuki; Setsuko Komuro
Journal:  Drug Metab Pharmacokinet       Date:  2011-03-04       Impact factor: 3.614

5.  Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human udp-glucuronosyltransferases.

Authors:  Verawan Uchaipichat; Peter I Mackenzie; David J Elliot; John O Miners
Journal:  Drug Metab Dispos       Date:  2005-12-28       Impact factor: 3.922

Review 6.  N-glucuronidation of drugs and other xenobiotics by human and animal UDP-glucuronosyltransferases.

Authors:  Sanna Kaivosaari; Moshe Finel; Mikko Koskinen
Journal:  Xenobiotica       Date:  2011-03-24       Impact factor: 1.908

7.  Determination of propofol UDP-glucuronosyltransferase (UGT) activities in hepatic microsomes from different species by UFLC-ESI-MS.

Authors:  Si-Cheng Liang; Guang-Bo Ge; Hui-Xin Liu; Hai-Tao Shang; Hong Wei; Zhong-Ze Fang; Liang-Liang Zhu; Yu-Xi Mao; Ling Yang
Journal:  J Pharm Biomed Anal       Date:  2010-08-13       Impact factor: 3.935

8.  The species differences of intestinal drug absorption and first-pass metabolism between cynomolgus monkeys and humans.

Authors:  Masayuki Takahashi; Takuo Washio; Norio Suzuki; Katsuhiro Igeta; Shinji Yamashita
Journal:  J Pharm Sci       Date:  2009-11       Impact factor: 3.534

9.  Effect of aging on glucuronidation of valproic acid in human liver microsomes and the role of UDP-glucuronosyltransferase UGT1A4, UGT1A8, and UGT1A10.

Authors:  Upendra A Argikar; Rory P Remmel
Journal:  Drug Metab Dispos       Date:  2008-10-06       Impact factor: 3.922

10.  Gossypol exhibits a strong influence towards UDP-glucuronosyltransferase (UGT) 1A1, 1A9 and 2B7-mediated metabolism of xenobiotics and endogenous substances.

Authors:  Yong-Sheng Zhang; Jun Yuan; Zhong-Ze Fang; Yan-Yang Tu; Cui-Min Hu; Gan Li; Liang Wang; Jian-Ping Deng; Jia-Jiu Yao; Hai-Rong Li
Journal:  Molecules       Date:  2012-04-27       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.